Moreover, activation of TLR4 by lipopolysaccharide (LPS) can upregulate programmed death-ligand 1 (PD-L1) levels and thereby attenuate the cytotoxicity of the killer T cells (CTL) and promote the tumor immune escape16,17. This evidence concerns the gene CD274 and neoplasm.